Willard H. Dere's Insider Trades & SAST Disclosures
Willard H. Dere's most recent trade in Seres Therapeutics Inc was a trade of 100,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on April 10, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Willard H. Dere.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Seres Therapeutics Inc | Willard H. Dere | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Mersana Therapeutics Inc | Willard H. Dere | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 55,000 | 55,000 | - | - | Stock Option (right to buy) | |
| Biomarin Pharmaceutical In... | Willard H. Dere | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 4,720 | 32,300 (0%) | 0% | 0 | Common Stock | |
| Seres Therapeutics Inc | Willard H. Dere | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2024 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Metagenomi Inc. | Willard H. Dere | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 78,636 | 78,636 | - | - | Stock Option (Right to Buy) | |
| Mersana Therapeutics Inc | Willard Dere H. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 6,112 | 39,182 (0%) | 0% | 0 | Common Stock | |
| Mersana Therapeutics Inc | Willard H. Dere | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 4,217 | 22,059 (0%) | 0% | 0 | Common Stock | |
| Mersana Therapeutics Inc | Willard H. Dere | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 18,355 | 18,355 | - | - | Stock Option (right to buy) | |
| Mersana Therapeutics Inc | Willard H. Dere | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 14,467 | 17,842 (0%) | 0% | 0 | Common Stock | |
| Biomarin Pharmaceutical In... | Willard H. Dere | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 4,190 | 27,580 (0%) | 0% | 0 | Common Stock | |
| Mersana Therapeutics Inc | Willard H. Dere | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 3,375 | 3,375 (0%) | 0% | 0 | Common Stock | |
| Seres Therapeutics Inc | Willard H. Dere | Director | Grant, award, or other acquisition of securities at price $ 3.15 per share. | 05 Jul 2022 | 31,746 | 31,746 (0%) | 0% | 3.2 | 100,000 | COMMON STOCK |
| Seres Therapeutics Inc | Willard H. Dere | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Mersana Therapeutics Inc | Willard H. Dere | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Biomarin Pharmaceutical In... | Willard H. Dere | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 4,980 | 23,390 (0%) | 0% | 0 | Common Stock | |
| Mersana Therapeutics Inc | Willard H. Dere | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 12,847 | 12,847 | - | - | Stock Option (right to buy) | |
| Mersana Therapeutics Inc | Willard H. Dere | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 25,050 | 25,050 | - | - | Stock Option (right to buy) | |
| Biomarin Pharmaceutical In... | Willard H. Dere | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 5,120 | 18,410 (0%) | 0% | 0 | Common Stock | |
| Mersana Therapeutics Inc | Willard H. Dere | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 3,141 | 3,141 | - | - | Stock Option (right to buy) | |
| Biomarin Pharmaceutical In... | Willard H. Dere | Director | Sale of securities on an exchange or to another person at price $ 123.61 per share. | 26 Jun 2020 | 4,430 | 13,290 (0%) | 0% | 123.6 | 547,592 | Common Stock |
| Mersana Therapeutics Inc | Willard H. Dere | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2020 | 9,200 | 9,200 | - | - | Stock Option (right to buy) | |
| Seres Therapeutics Inc | Willard H. Dere | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Biomarin Pharmaceutical In... | Willard H. Dere | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2020 | 4,300 | 17,720 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges